Clinical Trial

A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.

Name: A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis. — clinical trial record (NCT07180511)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy of QY201 tablets in the treatment of adult patients with moderate to severe atopic dermatitis (AD).

Trial Details

NCT Number	NCT07180511
Lead Sponsor	E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
Conditions	Atopic Dermatitis (AD)
Enrollment	460 participants
Start Date	2025-03-12
Primary Completion	2027-05-18 (estimated)
Study Completion	2027-07-19 (estimated)
Updated on ClinicalTrials.gov	2025-09-18